My protocol during this period: Retatrutide: 2mg weekly subcutaneous injection (ramped to 4mg by week 10) GHK-Cu: 1mg daily subcutaneous, rotated injection sites Cycle length: 12 weeks on, 4 weeks off Training: 4 days resistance training per week, 8,000 to 10,000 steps daily Protein intake: 130g daily minimum I sourced both from Red Fox Peptides
The catalytic core of tyrosinase is composed of H 2 L 2 tetramer, and its active center contains binuclear copper ions, which form a six-coordinated chelating structure through His61, His85, His94(CuA), His259, His263 and His296(CuB) ( 2+ is the key step to catalyze the oxidation of L-tyrosine to dopaquinone, which depends on the precise regulation of the hydrophobic environment in the active chamber ( CuA and CuB are connected by an oxygen bridge to form a rigid structure, required for catalytic activity
Injection protocol and administration Subcutaneous injection is the standard route for KLOW
In cases of injury in rats involving the mesenteric vein and pancreaticoduodenal vein, the blood vessel recruitment and angiogenesis induced by BPC-157 potentially contributed to reducing ischemia and mucosal injury in the abdominal organs
